ArticleOncotarget2019
TAK228 enhances antitumor activity of eribulin in triple negative breast cancer.
Nicci Owusu-Brackett et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleOncotarget2019
Nicci Owusu-Brackett et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.